These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9167522)

  • 1. Fluoroquinolone inhibition of clozapine metabolism.
    Markowitz JS; Gill HS; Devane CL; Mintzer JE
    Am J Psychiatry; 1997 Jun; 154(6):881. PubMed ID: 9167522
    [No Abstract]   [Full Text] [Related]  

  • 2. Clozapine case series.
    Sandson NB; Cozza KL; Armstrong SC; Eckermann G; Fischer BA; Phillips B
    Psychosomatics; 2007; 48(2):170-5. PubMed ID: 17329613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciprofloxacin increases serum clozapine and N-desmethylclozapine: a study in patients with schizophrenia.
    Raaska K; Neuvonen PJ
    Eur J Clin Pharmacol; 2000 Nov; 56(8):585-9. PubMed ID: 11151749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of clozapine and ciprofloxacin: a case report.
    Sambhi RS; Puri R; Jones G
    Eur J Clin Pharmacol; 2007 Sep; 63(9):895-6. PubMed ID: 17624521
    [No Abstract]   [Full Text] [Related]  

  • 5. Ciprofloxacin-phenytoin interaction.
    Brouwers PJ; de Boer LE; Guchelaar HJ
    Ann Pharmacother; 1997 Apr; 31(4):498. PubMed ID: 9101016
    [No Abstract]   [Full Text] [Related]  

  • 6. Comment: ciprofloxacin-phenytoin interaction.
    Pollak PT; Slayter KL
    Ann Pharmacother; 1997 Dec; 31(12):1549-50. PubMed ID: 9416402
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluoroquinolone-resistant Salmonella Paratyphi A.
    Adachi T; Sagara H; Hirose K; Watanabe H
    Emerg Infect Dis; 2005 Jan; 11(1):172-4. PubMed ID: 15714664
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluoroquinolone pharmacodynamics and efficacy.
    Doern GV; Tillotson GS
    Chest; 2001 Jul; 120(1):319-20. PubMed ID: 11451862
    [No Abstract]   [Full Text] [Related]  

  • 9. Comment: unexpectedly low phenytoin concentration in a patient receiving ciprofloxacin.
    McLeod R; Trinkle R
    Ann Pharmacother; 1998 Oct; 32(10):1110-1. PubMed ID: 9793610
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcium alginate-based antimicrobial film dressings for potential healing of infected foot ulcers.
    Ahmed A; Boateng J
    Ther Deliv; 2018 Feb; 9(3):185-204. PubMed ID: 29424287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory infections rather than antibiotics may increase clozapine levels: a critical review of the literature.
    de Leon J
    J Clin Psychiatry; 2004 Aug; 65(8):1144-5. PubMed ID: 15323602
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro activity and clinical efficacy of ciprofloxacin in otorhinolaryngeal infections.
    Speciale A; Blandino G; Caccamo F; Serra A
    Drugs; 1995; 49 Suppl 2():403-5. PubMed ID: 8549378
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of ciprofloxacin nonsusceptible urinary tract infections with ciprofloxacin.
    Jeffres MN; Shuster JE; Barclay SM
    Ann Pharmacother; 2011 Jun; 45(6):824-5. PubMed ID: 21666093
    [No Abstract]   [Full Text] [Related]  

  • 14. [Gonococcus: the disturbing development of strains resistant to ciprofloxacin].
    Nau JY
    Rev Med Suisse; 2006 Jan; 2(49):250. PubMed ID: 16493970
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical resistance to ciprofloxacin in Salmonella typhi.
    Rodrigues C; Mehta A; Andrews R; Joshi VR
    J Assoc Physicians India; 1998 Mar; 46(3):323-4. PubMed ID: 11273362
    [No Abstract]   [Full Text] [Related]  

  • 16. Morphological changes in Pseudomonas aeruginosa secondary to ciprofloxacin.
    Suvarna SK; al-Wali WI; Locke TJ
    Histopathology; 1997 Nov; 31(5):482-3. PubMed ID: 9416493
    [No Abstract]   [Full Text] [Related]  

  • 17. The rapid development of fluoroquinolone resistance in M. tuberculosis.
    Ginsburg AS; Woolwine SC; Hooper N; Benjamin WH; Bishai WR; Dorman SE; Sterling TR
    N Engl J Med; 2003 Nov; 349(20):1977-8. PubMed ID: 14614180
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluoroquinolone resistance trends and animal drug use: a retrospective analysis.
    Radostits OM
    Int J Infect Dis; 2004 May; 8(3):187-9; author reply 190-2. PubMed ID: 15109595
    [No Abstract]   [Full Text] [Related]  

  • 19. Fluoroquinolone prophylaxis for the prevention of bacterial infections in patients with cancer--is it justified?
    Murphy M; Brown AE; Sepkowitz KA; Bernard EM; Kiehn TE; Armstrong D
    Clin Infect Dis; 1997 Aug; 25(2):346-8. PubMed ID: 9332551
    [No Abstract]   [Full Text] [Related]  

  • 20. Ciprofloxacin resistance in Neisseria gonorrhoeae: trends in Hawaii, 1997-2002.
    Katz AR; Lee MV; Ohye RG; Whiticar PM; Effler PV
    Lancet; 2003 Aug; 362(9382):495. PubMed ID: 12927447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.